SCIENTURE HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
SCIENTURE HOLDINGS, INC. (SCNX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 2.00 million shares as of 2025-09-17, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-13
- SCIENTURE HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2019-12-31 was -12.10K shares.
- SCIENTURE HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2019 was 13.70K shares, a 223.64% increase from fiscal 2018.
- SCIENTURE HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2018 was 4.23K shares, a 87.90% decline from fiscal 2017.
- SCIENTURE HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2017 was 35.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2025-09-17 | 2.00M shares 10-Q · filed 2026-08-13 | ||||
| 2020-09-30 | 15.17K shares 10-Q · filed 2020-10-26 | ||||
| 2019-12-31 | -12.10K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | 13.70K shares 10-K · filed 2020-03-30 | |||
| 2019-09-30 | 25.80K shares 10-Q · filed 2019-10-28 | ||||
| 2018-12-31 | 4.23K shares 10-K · filed 2020-03-30 | 25.40K shares 10-K · filed 2019-03-22 | |||
| 2017-12-31 | 35.00K shares 10-K · filed 2019-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |